Expression of collagenase-1 (MMP-1) promotes melanoma growth through the generation of active transforming growth factor-beta
- PMID: 17625450
- DOI: 10.1097/CMR.0b013e3282a660ad
Expression of collagenase-1 (MMP-1) promotes melanoma growth through the generation of active transforming growth factor-beta
Abstract
Tumor cell invasion through basement membranes and into stromal tissue are key steps for promoting growth and metastasis. Tumor cells express various extracellular-matrix-degrading enzymes such as matrix metalloproteinases (MMPs) to degrade extracellular matrix components to facilitate tumor migration and invasion. Histological and clinical studies suggest a role for MMP-1 (collagenase-1) in malignant melanoma invasion. In this study, we evaluated MMP-1 in regulating malignant phenotypes of human melanoma cells by generating human melanoma cells stably transfected with pro-MMP-1 cDNA. The transfectants expressed the active form of MMP-1 associated with cells and showed enhanced invasive and growth abilities in type I collagen gel. Furthermore, MMP-1 expression promoted anchorage-independent growth, which was inhibited in the presence of type II transforming growth factor (TGF)-beta receptor:Fc fusion protein that scavenges TGF-beta receptors. Finally, we demonstrated that MMP-1 directly generated active TGF-beta from its latent form. Thus, these results suggest that MMP-1 produced from melanoma cells would play a role in tumor progression by both degrading matrix proteins and generating active growth factors such as TGF-beta in vivo.
Similar articles
-
Platelet-derived growth factor and transforming growth factor-beta modulate the expression of matrix metalloproteinases and migratory function of human airway smooth muscle cells.Clin Exp Allergy. 2009 Sep;39(9):1370-80. doi: 10.1111/j.1365-2222.2009.03293.x. Epub 2009 Jun 11. Clin Exp Allergy. 2009. PMID: 19522858
-
Expression of E1AF, an ets-oncogene transcription factor, highly correlates with malignant phenotype of malignant melanoma through up-regulation of the membrane-type-1 matrix metalloproteinase gene.Oncol Rep. 2008 May;19(5):1093-8. Oncol Rep. 2008. PMID: 18425363
-
Extracellular matrix-mediated membrane-type 1 matrix metalloproteinase expression in pancreatic ductal cells is regulated by transforming growth factor-beta1.Cancer Res. 2006 Jul 15;66(14):7032-40. doi: 10.1158/0008-5472.CAN-05-4421. Cancer Res. 2006. PMID: 16849548
-
Regulation of extracellular matrix remodeling following transforming growth factor-beta1/epidermal growth factor-stimulated epithelial-mesenchymal transition in human premalignant keratinocytes.Cells Tissues Organs. 2007;185(1-3):116-22. doi: 10.1159/000101312. Cells Tissues Organs. 2007. PMID: 17587817 Review.
-
Role of matrix metalloproteinases in melanoma cell invasion.Biochimie. 2005 Mar-Apr;87(3-4):307-14. doi: 10.1016/j.biochi.2005.01.013. Biochimie. 2005. PMID: 15781317 Review.
Cited by
-
Role of the Skin Microenvironment in Melanomagenesis: Epidermal Keratinocytes and Dermal Fibroblasts Promote BRAF Oncogene-Induced Senescence Escape in Melanocytes.Cancers (Basel). 2022 Feb 27;14(5):1233. doi: 10.3390/cancers14051233. Cancers (Basel). 2022. PMID: 35267541 Free PMC article.
-
Lipid raft localization of epidermal growth factor receptor alters matrix metalloproteinase-1 expression in SiHa cells via the MAPK/ERK signaling pathway.Oncol Lett. 2016 Dec;12(6):4991-4998. doi: 10.3892/ol.2016.5307. Epub 2016 Oct 24. Oncol Lett. 2016. PMID: 28101233 Free PMC article.
-
Influence of single nucleotide polymorphisms in the MMP1 promoter region on cutaneous melanoma progression.Melanoma Res. 2012 Apr;22(2):169-75. doi: 10.1097/CMR.0b013e32834fc46b. Melanoma Res. 2012. PMID: 22198560 Free PMC article.
-
Green Synthesized Honokiol Transfersomes Relieve the Immunosuppressive and Stem-Like Cell Characteristics of the Aggressive B16F10 Melanoma.Int J Nanomedicine. 2021 Aug 24;16:5693-5712. doi: 10.2147/IJN.S314472. eCollection 2021. Int J Nanomedicine. 2021. PMID: 34465990 Free PMC article.
-
Matrix metalloproteinases stimulate epithelial-mesenchymal transition during tumor development.Clin Exp Metastasis. 2008;25(6):593-600. doi: 10.1007/s10585-008-9143-9. Epub 2008 Feb 20. Clin Exp Metastasis. 2008. PMID: 18286378 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources